|
Neonatal Intensive Care Drug Manual
|
| bet | 484/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Trade Name
|
Prevenar 13.
|
Presentation
|
Suspension in pre-filled syringe.
|
Dosage / Interval
|
0.5 mL.
|
Dose adjustment
|
|
Maximum dose
|
|
Route
|
IM
|
Preparation/Dilution
|
|
Administration
|
1. May administer oral sucrose 2 minutes prior to injection (observe local pain policy).
2. Shake syringe vigorously immediately prior to use to obtain an homogenous, white suspension.
3. Administer 0.5 ml of suspension by intramuscular injection (IMI) to the anterolateral aspect of the thigh (slowly to reduce pain).
4. Administer on the opposite limb from other concurrently administered vaccines (e.g. INFANRIX hexa).
|
Monitoring
|
1. Observe for 15 minutes after vaccination for any Adverse Event Following Immunisation (AEFI).
2. Pain: Refer to local pain relief policy.
3. Body temperature.
4. Infants with a history of febrile convulsions should be closely followed up as such adverse events may occur within 2 to 3 days post-vaccination.
|
|
|
| |
